论文部分内容阅读
六十年代中期,为了验证降低增高的血清胆固醇能减少缺血性心脏病的假设,世界卫生组织用当时认为有效而且安全的安妥明进行了一次试验。这个试验的首次报告指出:给予安妥明的健康人与随机选择的对照组相比,非致命性心肌梗塞的发病率减少25%,首次严重冠状动脉意外减少20%,但首次致命性心脏病的发生率没有减少。在安妥明治疗
In the mid-1960s, to test the hypothesis that lowering elevated serum cholesterol reduces ischemic heart disease, WHO conducted an experiment with what was then considered effective and safe. The first report of this trial states that the incidence of non-fatal myocardial infarction was reduced by 25% in healthy subjects given statin compared to a randomly selected control, with a 20% reduction in the first severe coronary artery accident but the first fatal heart attack The incidence did not decrease. Treatment with clofibrate